1.
Get more info on this report!
Remote & Wireless Patient Monitoring Markets
May 1, 2010
Patient monitoring systems are emerging in response to increased healthcare needs of
an aging population, new wireless technologies, better video and monitoring
technologies, decreasing healthcare resources, an emphasis on reducing hospital days,
and proven cost-effectiveness.
Of these new high-tech patient monitoring systems, nearly all focus on some form of
wireless or remote patient monitoring. Advances in remote patient monitoring include
new peripherals, real-time audio and video for “face-to-face” interaction between
clinicians and patients, wireless communication, systems that “sort” the vast amount of
data collected in order to put it into the context of a patient’s condition, portable and
ambulatory monitors, web-based access to the patient record, systems that transfer
data to an electronic medical record (EMR), and full-service outsourcing that includes a
clinician to evaluate data and send a report to the attending physician.
This Kalorama Information report, Remote & Wireless Patient Monitoring Markets
covers three product areas: wireless and remote patient monitors, patient data
processing applications and equipment, and EMR data transfer equipment and
applications, which coordinate the flow of data to hospital electronic medical record
system. Wireless and remote technologies include all patient monitoring that transmit
data either within an institution via wireless or intranet, and all technologies that monitor
a patient and forward the data to another party or application. There are four primary
markets for these new technologies, which are as follows:
• Hospitals;
• Home healthcare;
• Nursing homes; and
• Other (including first responders, institutional, physician offices, and
military)
This report breaks out the market for high tech remote and wireless patient monitoring
systems by these usage areas. But the report also by disase category for the following

2. areas:
• Asthma
• COPD
• CHF
• CHD
• Diabetes
• Other
Patient data processing applications and equipment use algorithms to evaluate
monitoring measurements for a patient’s specific condition(s). Usually, these can be
customized by the physician, with reports sent to the physician. In the market for high-
tech patient monitoring systems, the applications and equipment are either integrated
into the patient monitoring system or are add-ons to the measuring systems. As with
data processing, EMR data transfer equipment and applications for this report are either
components of, or add-ons to, patient monitoring systems. This report does not include
EMR applications. In general, the applications in this segment transfer data to third-
party EMRs.
Most players in the market are discussed as part of Kalorama's competitive analysis of
the remote patient monitoring market. As part of our coverage of the marketplace for
remote and wireless systems, the followiing companies are profiled in detail in this
report:
• Abbott Laboratories, Inc
• Aerotel Medical Systems
• GE Healthcare
• Honeywell HomMed LLC
• Intel Corporation
• Philips Medical Systems
• Roche Diagnostics Corporation
This report was constructed using both a primary and secondary research approach.
Annual reports, trade publications and other sources were thoroughly researched, but
interviews were conducted among industry executives were used to make assessments
of markets and to discover trends and construct forecasts.
In addition to being a resource for major pharmaceutical, diagnostic and healthcare IT
companies, Kalorama Information has been utilized by: The Economist, The New York
Times, The Wall Street Journal, Health and Imaging IT Magazine, Fierce EMR, and
many other publications for reporting on markets.

3. Table of Contents
TABLE OF CONTENTS
CHAPTER ONE: EXECUTIVE SUMMARY
• Introduction
• Scope and Methodology
• Products
• Issues and Trends
• Size and Growth of the Market
• Leading Competitors
• Forecast
CHAPTER TWO: INTRODUCTION
Overview
Aging of the Population
New Technologies
• Wireless Technologies
• Remote Monitoring
• Telemedicine
• Applications to Sort Data by Disease State
• EMR (EHR) Data Transfer Applications and Equipment
Proven Cost Effectiveness
Barriers to Use of New Technologies in Patient Monitoring
Forecasts
CHAPTER THREE: PRODUCTS
• Overview
• Offerings
o Abbott
o American Medical Development (AMD) Telemedicine Products
o American TeleCare
o Cardiocom
o Carematix
o Cybernet Medical Corporation
o Drager Medical
o GE Healthcare

4. o Global Media
o Honeywell HomMed
o iMetrikus
o InTouch Health
o LifeWatch Technologies
o MedApps
o Medtronic
o Philips Medical Systems
o Roche
o St. Jude Medical
o Second Opinion Software
o Viterion TeleHealthcare
o Welch Allyn
o WebVMC
CHAPTER FOUR: ISSUES AND TRENDS
• Introduction
• Issues and Trends Driving the Market
o Aging of the Population
o New Wireless Technologies
o Decreasing Healthcare Resources
o Emphasis on Reducing Hospital Days
o Nursing Shortage
o Cost Effectiveness
• Issues and Trends in Patient Monitoring Technologies
o Audio and Video
o Algorithms to “Sort” Data or Trigger Alarms
o Off-site Access to Data
o Full-service Outsourcing
o Data Management and the Electronic Medical Record
o Turnkey Systems
o Disease Management Kits
o HIPAA
o System Compatibility
CHAPTER FIVE: TOTAL MARKET SIZE AND FORECAST
• Overview
• Disease States
o Asthma
o COPD
o CHF
o CHD
o Diabetes

5. • Total Market Size and Forecast
• Technologies
o Wireless and Remote Patient Monitors
o Patient Data Processing Applications and Equipment
o Equipment and Applications to Transfer Data to EMRs
• End-User Markets
o Hospitals
o Home Healthcare
o Nursing Homes
o Other
• Disease States
o Asthma
o COPD
o CHF
o CHD
o Diabetes
o Other
CHAPTER SIX: CORPORATE PROFILES
• Introduction
• Abbott Laboratories, Inc
• GE Healthcare
• Honeywell HomMed LLC
• Medtronic, Inc.
• Philips Medical Systems
• Roche Diagnostics Corporation
APPENDIX A: REGULATORY AUTHORITIES AND ORGANIZATIONS
APPENDIX B: LIST OF COMPANIES
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
• Table 1-1: The U.S. Market for High-Tech Patient Monitoring Systems 2007-2014
• Figure 1-1: The U.S. Market for High-Tech Patient Monitoring Systems 2007-2014
CHAPTER THREE PRODUCTS
• Table 3-1: Select Patient Monitoring Systems
• Table 3-2: Select Patient Monitoring Systems January 2008
CHAPTER FOUR: ISSUES AND TRENDS

6. • Table 4-1: Projected Population of the United States, by Age: 2000 to 2050
• Figure 4-1: Population Aged 65 and Over, and 85 and Over 2000 to 2050
• Figure 4-2: Percent of Population Aged 65 and Over, and 85 and Over 2000 to 2050
• Table 4-2: Resident Population Projections: 2007 to 2050, July 1
• Table 4-3: National Health Expenditure Amounts, by Type of Expenditure: Calendar Years 2001-2015
• Table 4-4: Per Capita Healthcare Expenditures, 2001-2015
• Table 4-5: Percent of Office-based Physicians Using EMRs (EHRs), by Number of Physicians in
Practice, 2006
• Figure 4-2: Percent of Office-based Physicians Using EMRs, by Number of Physicians in Practice, 2006
• Table 4-6: Percent of Office-based Physicians Using EMRs, 2001-2006 Figure 4-3: Percent of Office-
based Physicians Using EMRs, 2001-2006
• Table 4-7: Percent of Medical Practices Using EMRs, by Selected Years: 2003-2006
• Figure 4-4: Percent of Medical Practices Using EMRs, by Selected Years: 2003-2006
• Table 4-8: Percentage of Office-based Physicians Reporting Fully or Partially Electronic EMR Systems:
United States, 2006
• Table 4-8: Use of Electronic Medical Records by Location Characteristics of Office-based Physicians:
United States, 2006
CHAPTER FIVE: TOTAL MARKET SIZE AND FORECAST
• Table 5-1: U.S. Prevalence of Asthma, COPD, CHF, CHD, and Diabetes 2007 and 2012
• Figure 5-1: U.S. Prevalence of Asthma, COPD, CHF, CHD, and Diabetes 2007 and 2012
• Table 5-2: U.S. Prevalence of Asthma, COPD, CHF, CHD, and Diabetes Among Americans Aged 65
and Over 2007 and 2012
• Figure 5-2: U.S. Prevalence of Asthma, COPD, CHF, CHD, and Diabetes Among Americans Aged 65
and Over 2007 and 2012
• Table 5-3: U.S. Direct and Indirect Morbidity Costs of Asthma, COPD, CHF, CHD, and Diabetes 2007
• Figure 5-3: U.S. Direct and Indirect Morbidity Costs of Asthma, COPD, CHF, CHD, and Diabetes 2007
• Figure 5-4: Percent Distribution of U.S. Direct Costs of Asthma, COPD, CHF, CHD, and Diabetes 2007
• Table 5-4: The U.S. Market for New Technologies in Patient Monitoring 2007-2014
• Figure 5-5: The U.S. Market for New Technologies in Patient Monitoring 2007-2014
• Table 5-5: The U.S. Market for New Technologies in Patient Monitoring, by Technology Type (Wireless,
Data Processing, EMR Data Transfer) 2007-2014
• Figure 5-6: The U.S. Market for New Technologies in Patient Monitoring, by Technology Type 2007-2014
• Figure 5-7: The U.S. Market for New Technologies in Patient Monitoring, by Technology Type 2007
• Figure 5-8: The U.S. Market for New Technologies in Patient Monitoring, by Technology Type 2012
• Table 5-6: The U.S. Market for Wireless and Remote Patient Monitoring Technologies 2007-2014
• Figure 5-9: The U.S. Market for Wireless and Remote Patient Monitoring Technologies 2007-2014
• Table 5-7: The U.S. Market for Patient Data Processing Applications and Equipment 2007-2014
• Figure 5-10: The U.S. Market for Patient Data Processing Applications and Equipment 2007-2014
• Table 5-8: The U.S. Market for EMR Data Transfer Equipment and Applications 2007-2014
• Figure 5-11: The U.S. Market for EMR Data Transfer Applications and Equipment 2007-2014
• Table 5-9: The U.S. Market for New Technologies in Patient Monitoring, by End User (Hospitals, Home
Healthcare, Nursing Homes, Other) 2007-2014

7. • Figure 5-12: The U.S. Market for New Technologies in Patient Monitoring, by End User Type (Hospitals,
Home Healthcare, Nursing Homes, Other) 2007-2014
• Figure 5-13: The U.S. Market for New Technologies in Patient Monitoring, by End User Type (Hospitals,
Home Healthcare, Nursing Homes, Other) 2007
• Figure 5-13: The U.S. Market for New Technologies in Patient Monitoring, by End User Type (Hospitals,
Home Healthcare, Nursing Homes, Other) 2012
• Table 5-10: The U.S. Market for New Technologies in Patient Monitoring in Hospitals 2007-2014
• Figure 5-13: The U.S. Market for New Technologies in Patient Monitoring in Hospitals 2007-2014
• Table 5-11: The U.S. Market for New Technologies in Patient Monitoring in Home Healthcare 2007-2014
• Figure 5-14: The U.S. Market for New Technologies in Patient Monitoring in Home Healthcare 2007-
2014
• Table 5-12: The U.S. Market for New Technologies in Patient Monitoring in Nursing Homes 2007-2014
• Figure 5-15: The U.S. Market for New Technologies in Patient Monitoring in Nursing Homes 2007-2014
• Table 5-13: The U.S. Market for New Technologies in Patient Monitoring in Other End Uses 2007-2014
• Figure 5-16: The U.S. Market for New Technologies in Patient Monitoring in Other End Uses 2007-2014
• Table 5-14: The U.S. Market for New Technologies in Patient Monitoring, by Disease State 2007-2014
(Asthma, COPD, CHF, CHD, Diabetes, Other)
• Figure 5-17: The U.S. Market for New Technologies in Patient Monitoring, by Disease State (Asthma,
COPD, CHF, CHD, Diabetes, Other) 2007-2014
• Figure 5-18: The U.S. Market for New Technologies in Patient Monitoring, by Disease State (Asthma,
COPD, CHF, CHD, Diabetes, Other) 2007
• Figure 5-19: The U.S. Market for New Technologies in Patient Monitoring, by Disease State (Asthma,
COPD, CHF, CHD, Diabetes, Other) 2012
• Table 5-15: The U.S. Market for New Technologies in Patient Monitoring Asthma 2007-2014
• Figure 5-20: The U.S. Market for New Technologies in Patient Monitoring of Asthma 2007-2014
• Table 5-16: The U.S. Market for New Technologies in Patient Monitoring of COPD 2007-2014
• Figure 5-21: The U.S. Market for New Technologies in Patient Monitoring of COPD 2007-2014 Table 5-
17: The U.S. Market for New Technologies in Patient Monitoring of CHF 2007-2014
• Figure 5-22: The U.S. Market for New Technologies in Patient Monitoring CHF 2007-2014
• Table 5-18: The U.S. Market for New Technologies in Patient Monitoring of CHD 2007-2014
• Figure 5-23: The U.S. Market for New Technologies in Patient Monitoring of CHD 2007-2014
• Table 5-19: The U.S. Market for New Technologies in Patient Monitoring of Diabetes 2007-2014
• Figure 5-24: The U.S. Market for New Technologies in Patient Monitoring of Diabetes 2007-2014
• Table 5-20: The U.S. Market for New Technologies in Patient Monitoring of Other Conditions 2007-2014
• Figure 5-25: The U.S. Market for New Technologies in Patient Monitoring of Other Conditions 2007-2014
CHAPTER SIX: CORPORATE PROFILES
• Table 6-1 Other Companies and Products
Available immediately for Online Download at
http://www.marketresearch.com/product/display.asp?productid= 2645944

8.
US: 800.298.5699
UK +44.207.256.3920
Int'l: +1.240.747.3093
Fax: 240.747.3004